Cartesian Therapeutics, Inc.
RNAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001453687
No open-market purchases or sales by Cartesian Therapeutics, Inc. insiders were filed in the last 90 days; 94 institutions reported holding it in 13F filings for Q2 2026, worth $90.4M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Cartesian Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 101
- +3 vs. Q1 2021
- Shares held
- 52.4M
- −1.81M (−3.3%) vs. Q1 2021
- Total value
- $219.2M
- −$26.0M (−10.6%) vs. Q1 2021
- New holders
- 18
- 38 more added
- Sold out
- 15
- 29 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RNAC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 94 | $90.4M |
| Q1 2026 | 83 | $43.9M |
| Q4 2025 | 67 | $37.2M |
| Q3 2025 | 68 | $60.9M |
| Q2 2025 | 66 | $66.5M |
| Q1 2025 | 72 | $86.7M |
| Q4 2024 | 68 | $119.5M |
| Q3 2024 | 64 | $110.3M |
| Q2 2024 | 62 | $88.3M |
| Q1 2024 | 70 | $35.3M |
| Q4 2023 | 80 | $37.8M |
| Q3 2023 | 87 | $57.2M |
| Q2 2023 | 92 | $63.2M |
| Q1 2023 | 95 | $65.1M |
| Q4 2022 | 86 | $62.8M |
| Q3 2022 | 97 | $104.9M |
| Q2 2022 | 93 | $79.3M |
| Q1 2022 | 102 | $71.6M |
| Q4 2021 | 106 | $185.7M |
| Q3 2021 | 103 | $216.7M |
| Q2 2021 | 101 | $219.2M |
| Q1 2021 | 98 | $245.1M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Cartesian Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 6,690,989 | $28.0M | 0.00% | +448,902+7.2% | Added |
| Polaris Venture Management Co. V, L.L.C. | 0 | $0 | 0.00% | −2,773,479−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −339,169−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −142,100−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −71,376−100.0% | Sold out |
| Wealthstreet Investment Advisors, LLC | 0 | $0 | 0.00% | −37,000−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −33,413−100.0% | Sold out |
| SG3 Management, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −21,880−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −19,768−100.0% | Sold out |
| Verdence Capital Advisors LLC | 0 | $0 | 0.00% | −17,000−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −12,438−100.0% | Sold out |
| Kingsview Wealth Management, LLC | 0 | $0 | 0.00% | −11,100−100.0% | Sold out |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −34−100.0% | Sold out |